Shehla Shaikh

ORCID: 0000-0002-5977-4524
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dietary Effects on Health
  • Diabetes Treatment and Management
  • Diabetes Management and Research
  • Diabetes Management and Education
  • Pharmacology and Obesity Treatment
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Metabolism, Diabetes, and Cancer
  • Obesity and Health Practices
  • Pancreatic function and diabetes
  • Bariatric Surgery and Outcomes
  • Lipoproteins and Cardiovascular Health
  • Optimism, Hope, and Well-being
  • Chronic Disease Management Strategies
  • Hormonal Regulation and Hypertension
  • Cardiovascular Health and Risk Factors
  • Health Systems, Economic Evaluations, Quality of Life
  • Travel-related health issues
  • Regulation of Appetite and Obesity
  • Diet and metabolism studies
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Nutritional Studies and Diet
  • Appendicitis Diagnosis and Management
  • Health Promotion and Cardiovascular Prevention
  • Berberine and alkaloids research
  • Adrenal and Paraganglionic Tumors

Keck Hospital of USC
2025

University of Southern California
2025

Sir H.N. Reliance Foundation Hospital and Research Centre
2024

Saifee Hospital
2012-2024

Lupin Pharmaceuticals (India)
2024

Christian Medical College & Hospital
2024

Bharti Hospital
2023-2024

Scientific Services
2024

Ruby Hall Clinic
2024

Diabetes Care & Hormone Clinic
2024

Bernard Zinman Vanita R. Aroda John B. Buse Bertrand Cariou Stewart B. Harris and 95 more Søren T. Hoff Karen Boje Pedersen Mads Jeppe Tarp-Johansen Eiichi Araki Bernard Zinman Sameh Fikry Harpreet S. Bajaj Daniel Landry David Caplan Vincent Woo Stewart B. Harris Jean-Francois Thuan Pierre Sérusclat Bertrand Cariou Pierre Gourdy G. Fradet Arnaud Monier Sophie Borot P. Monguillon D. Gouet John Doupis Nikolaοs Tentolouris V. Tsimichodimos Andreas Melidonis Eleni Bekiari Αlexandra Bargiota Sanjay Agarwal Banshi Saboo Sanjay Chatterjee Viswanathan Mohan Shehla Shaikh Yashdeep Gupta Arpandev Bhattacharyya Neeraj Manikath Sunil Jain Takashi Sasaki Takeshi Osonoi Shuichi Fukuda Seiki Wada Arihiro Kiyosue Yumiko Ide Yukiko Onishi Kiyokazu Matoba Kuninobu Takai Akira Yamauchi Satoshi Inoue Shizuka Kaneko Hiroki Ikeda Yasuharu Ohta Akitaka Hisatomi Takafumi Senokuchi Hideaki Jinnouchi Shuji Nakamura José Roberto Lazcano Soto Ignacio Rodríguez Briones Paweł Bogdański Ewa Szyprowska Anna Modzelewska Iwona Wozniak S. T. Zyangirova M. Sergeeva-Kondrachenko Thomas R. A. Davis Stephen P. Thomson Juan P. Frías Winston Gandy Ildiko Lingvay Kevin Pounds Cynthia Bowman-Stroud Michael Dempsey David Huffman Azazuddin Ahmed Neil Fraser Ramon Ortiz-Carrasquillo D. Eric Bolster Michael Adams Matthew A. Hummel Almena Free Patricia Houser Gerald Shockey Otis Barnum Kala R. Bhasker George Mitchell Cornett Dan Streja William Kirby Sean Lynd Steven Folkerth Samer Nakhle Paul Norwood Rodolfo Pérez Brian D. Snyder Neil Farris Willian Litchfield Osama Hamdy Jean Park Vanita R. Aroda

OBJECTIVE To investigate the efficacy, safety, and tolerability of oral semaglutide added to insulin with or without metformin. RESEARCH DESIGN AND METHODS Patients type 2 diabetes uncontrolled on metformin were randomized 3 mg (N = 184), 7 182), 14 181) placebo 184) in a 52-week, double-blind trial. End points change from baseline week 26 HbA1c (primary) body weight (confirmatory secondary). Two estimands defined: treatment policy (effect regardless trial product discontinuation rescue...

10.2337/dc19-0898 article EN Diabetes Care 2019-07-10

Statins are an established class of drugs with proven efficacy in cardiovascular risk reduction. The concern over statin safety was first raised the revelation myopathy and rhabdomyolysis use now withdrawn cerivastatin. Enhanced understanding mechanisms behind adverse effects statins including insight into pharmacokinetic properties have minimised fear among clinicians. Studies reveal that occurrence rare 1/100000 patient-years. myopathy/rhabdomyolysis varies between due to varying profiles....

10.4103/2230-8210.113754 article EN cc-by-nc-sa Indian Journal of Endocrinology and Metabolism 2013-01-01

ABSTRACT Background Solid organ transplant (SOT) recipients residing in southwestern United States may be at an increased risk of symptomatic coccidioidomycosis (CM). Accordingly, clinical practice guidelines recommend the use a universal oral azole antifungal prevention strategy for all SOT CM endemic area. However, this recommendation is based on limited evidence. Our center does not routinely utilize prophylaxis low de novo infection. Objective To determine incidence with or without...

10.1111/tid.70004 article EN cc-by-nc-nd Transplant Infectious Disease 2025-02-18

Imeglimin is a novel oral antidiabetic drug that was approved for use in India October 2022. Thus far, no large-scale studies on the effectiveness and safety of imeglimin treatment type-2 diabetes mellitus (T2DM) have been conducted Indian population. The objective this study to evaluate patients with T2DM real-world setting. This observational, retrospective, at 191 sites across from May June 2024. Adult uncontrolled (7% ≤ glycated hemoglobin (HbA1c) 9%) who were prescribed 1000 mg twice...

10.1007/s13300-025-01693-z article EN cc-by-nc Diabetes Therapy 2025-02-19

To explore the real-world safety and effectiveness of gliclazide modified release (MR) in patients with type 2 diabetes mellitus (T2DM) fasting during Ramadan.DIA-RAMADAN (NCT04132934) was a prospective, international, observational study conducted nine countries. Patients >18 years age T2DM (N = 1244) were examined at an inclusion visit (V0) occurring 6-8 weeks before start Ramadan. received diary to report treatment changes, hypoglycaemic events (HEs), other adverse events. Gliclazide MR...

10.1016/j.diabres.2020.108154 article EN cc-by-nc-nd Diabetes Research and Clinical Practice 2020-04-21

The DAR Global survey of Ramadan-fasting during the COVID-19 pandemic aimed to describe characteristics and care in participants with type 2 diabetes (T2D) a specific comparison between those <65 years ≥65 years.Participants were consented answer physician-administered questionnaire following Ramadan 2020. Impact on decision fasting, intentions fast duration Shawal hypoglycaemia hyperglycaemia events assessed. Specific analysis comparing age categories performed.Among 5865 participants,...

10.1016/j.diabres.2021.108674 article EN other-oa Diabetes Research and Clinical Practice 2021-01-23

Background Type 2 diabetes mellitus (T2DM) worldwide continues to increase, in particular India. Early T2DM diagnosis followed by appropriate management will result more cardiovascular event free life years. However, knowledge of the profile newly diagnosed patients is still limited. The aim this study was understand extent disease (CVD) risk Methods A cross sectional observational conducted evaluate clinical laboratory and socio-demographic parameters 5,080 (48.3 ± 12.8 years age; 36.7%...

10.1371/journal.pone.0263619 article EN cc-by PLoS ONE 2022-03-31

To compare the efficacy and safety of insulin degludec/insulin aspart (IDegAsp) biphasic 30 (BIAsp 30) before, during after Ramadan in patients with type 2 diabetes mellitus (T2DM) who fasted Ramadan.In this multinational, randomised, treat-to-target trial, T2DM intended to fast were on basal, pre- or self-mixed ± oral antidiabetic drugs for ≥90 days randomised (1:1) IDegAsp twice daily (BID) BIAsp BID. Treatment period included pre-Ramadan treatment initiation (with titration 8-20 weeks),...

10.1016/j.diabres.2017.11.027 article EN cc-by-nc-nd Diabetes Research and Clinical Practice 2017-11-26

Introduction: A novel clinical calculator was developed to assist physicians in classifying the risk for individuals with diabetes planning observe fasting during holy month of Ramadan. The aim this study evaluate necessity use approach. Methods: survey twenty-six scenario questions developed. All cases were pre-scored using proposed Diabetes and Ramadan Risk Calculator. sent 350 reputable practicing considerable expertise managing patients diabetes. sought expert opinion on patients’...

10.1159/000527474 article EN cc-by-nc Dubai Diabetes and Endocrinology Journal 2023-01-01

The DAR 2020 survey summarised fasting practices and complications in people with type 2 diabetes (T2D) who fasted during Ramadan, impact of pre-Ramadan education towards controlling the complications. Eight week post-Ramadan, Muslim T2D from 13 countries five regions (South Asia, Southeast Gulf Nations, Middle East North Africa) consented to answer questionnaire on breaking fast, hypoglycaemia, hyperglycaemia, Ramadan-focused self-monitoring blood glucose (SMBG). Among 4889 participants...

10.1016/j.deman.2024.100229 article EN cc-by-nc-nd Diabetes Epidemiology and Management 2024-06-21

Abstract Background The thyroid-stimulating hormone (TSH) levels increase with age, and aiming for the same TSH target applicable in a younger population older patients who are on replacement thyroid hormones. Methods We assessed practice patterns regarding goals explored factors influencing physicians' decision-making when managing hypothyroidism. Multiple-choice questions case-based survey of convenience sample physicians practicing relevant disciplines three developing regions. Results Of...

10.1055/s-0044-1789211 article EN cc-by-nc-nd Journal of Diabetes and Endocrine Practice 2024-07-01
Coming Soon ...